A detailed history of Headlands Technologies LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 12 shares of TXG stock, worth $237. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 1,892 99.37%
Holding current value
$237
Previous $71,000 100.0%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$19.45 - $37.37 $36,566 - $70,255
-1,880 Reduced 99.37%
12 $0
Q1 2024

May 07, 2024

BUY
$36.08 - $54.3 $68,263 - $102,735
1,892 New
1,892 $71,000
Q3 2023

Nov 09, 2023

SELL
$40.86 - $62.98 $167,403 - $258,029
-4,097 Reduced 88.68%
523 $21,000
Q2 2023

Aug 03, 2023

BUY
$50.96 - $58.72 $235,435 - $271,286
4,620 New
4,620 $257,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.88B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.